Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Biopharm Drug Dispos. 2011 Sep 22;32(8):471–481. doi: 10.1002/bdd.770

Figure 6.

Figure 6

Change from baseline in lumbar spine BMD after multiple SC doses of denosumab. Regimens are 6, 14, and 30 mg of denosumab given every 3 months to postmenopausal women with low BMD. Symbols represent data from the literature [10] and lines represent model-fitted profiles using the integrated bone homeostasis model.